Alere Inc. Inverness Medical Innovations, Inc. Series B Convertible Perpetual Preferred Stock Assigned Short-Term B2 & Long-Term Ba2 Credit Rating

Larger, investment-grade issuers that have access to both public and private debt markets have greater flexibility than companies that depend solely on private bank loans. In addition, we consider whether a company can borrow on an unsecured basis, has access to the commercial paper markets, and issues debt in multiple geographies. It is more costly to raise debt in the public bond markets and often requires a company to establish a track record among investors. These costs and information asymmetry issues sometimes make it impractical for smaller, speculative-grade issuers to raise small amounts of debt in public markets.Alere Inc. Inverness Medical Innovations, Inc. Series B Convertible Perpetual Preferred Stock Assigned Short-Term B2 & Long-Term Ba2 Credit Rating. How Does Credit Rating Model Work?

Rating Model for Alere Inc. Inverness Medical Innovations, Inc. Series B Convertible Perpetual Preferred Stock: We estimate the credit risk parameters by Price and Simple Regression

Credit Ratings for Alere Inc. Inverness Medical Innovations, Inc. Series B Convertible Perpetual Preferred Stock as of 06 Apr 2022

Credit Rating	Short-Term	Long-Term Senior
AI Rating Class*	B2	Ba2
Semantic Signals	56	84
Financial Signals	50	68
Risk Signals	36	77
Substantial Risks	80	66
Speculative Signals	60	41

*Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines.Take a look at: How Does Credit Rating Model Work?

Financial Analysis for Alere Inc. Inverness Medical Innovations, Inc. Series B Convertible Perpetual Preferred Stock

Financials: PREMIUM
Income Statement: PREMIUM
Balance Sheet: PREMIUM
Cash Flow: PREMIUM
Valuation: PREMIUM
Inventory Valuation: PREMIUM
Dividends: PREMIUM
Operating Performance: PREMIUM
Sustainability: PREMIUM
Price vs. Fair Value: PREMIUM
Stock Analysis: PREMIUM

Analyst Rating for Alere Inc. Inverness Medical Innovations, Inc. Series B Convertible Perpetual Preferred Stock

Is it the right time to buy or sell? : PREMIUM
Fair Value : PREMIUM
Trailing Returns : PREMIUM

Key Statistics for Alere Inc. Inverness Medical Innovations, Inc. Series B Convertible Perpetual Preferred Stock

Price/Book : PREMIUM
Price/Cash Flow : PREMIUM
Price/Sales : PREMIUM
Price/Earnings : PREMIUM
Operating Income : PREMIUM
Net Income : PREMIUM
Quick Ratio : PREMIUM
Current Ratio : PREMIUM
Interest Coverage : PREMIUM
Debt/Equity : PREMIUM
Return on Assets : PREMIUM
Return on Equity : PREMIUM
Invested Capital : PREMIUM
Net Margin : PREMIUM
EBITDA Margin : PREMIUM
Days Sales Outstanding : PREMIUM
Payables Period : PREMIUM
Cash Conversion Cycle : PREMIUM
Recieveables Turnover : PREMIUM
Inventory Turnover : PREMIUM
Fixed Assets Turnover : PREMIUM
Asset Turnover : PREMIUM
Operating Cash Flow Growth : PREMIUM
Free Cash Flow Growth : PREMIUM
Free Cash Flow/Sales : PREMIUM
Free Cash Flow/Net Income : PREMIUM
Free Cash Flow/Share : PREMIUM

Credit Report for Alere Inc. Inverness Medical Innovations, Inc. Series B Convertible Perpetual Preferred Stock

Risk Report : PREMIUM
Credit Report : PREMIUM
Commercial Credit Report : PREMIUM

Audit Reports & Filings for Alere Inc. Inverness Medical Innovations, Inc. Series B Convertible Perpetual Preferred Stock

Audit Reports : PREMIUM
Principal Risk and Viability : PREMIUM
Risk Analysis : PREMIUM
Retail Technology Environment, Including IT Security : PREMIUM
SEC Filings : PREMIUM
Bankruptcy Filings : PREMIUM
Suit & Judgment Filings : PREMIUM
Tax Lien Filings : PREMIUM

Market Research for Alere Inc. Inverness Medical Innovations, Inc. Series B Convertible Perpetual Preferred Stock

Customer Reviews : 9407 reviews PREMIUM
Interviews : PREMIUM
Focus Groups : PREMIUM
Market Share Analysis : PREMIUM